Key figures

Radiation oncology:
Nine and a half FTE medical staff, 8.3 FTE clinical residents, 9.8 FTE medical physicists, 3.7 FTE medical physics assistants, 9.2 FTE radiation technologists and 19.5 FTE nurses are responsible for daily patient care.
In addition, 11 PhD students and two post-doctoral researchers.

Prof. dr. K. Haustermans
UZ Leuven – Dep. of Radiation Oncology
Herestraat 49 3000 Leuven

Nuclear medicine
https://gbiomed.kuleuven.be/english/research/50000677/50000683
koen.vanlaere@uzleuven.be

Radiopharmacy
guy.bormans@kuleuven.be

Radiopharmacy GMP facility
kim.serdons@uzleuven.be

https://www.kuleuven.be/kankerinstituut/en/research/radiotherapy
Karin.Haustermans@uzleuven.be
+32 16 347600
UZ Leuven

Radiation oncology

The radiation oncology department is located at Gasthuisberg, the main location of UZ Leuven. It is now officially imbedded in the Leuven Cancer Institute and plays a pivotal role in fostering interdisciplinary collaboration in research. Hence, advances in basic science can easily be translated into innovative approaches in clinical practice. Our department is equipped with a ProteusOne system for proton therapy, five linear accelerators, a HDR afterloader and two CT simulators.

 

Research and clinical axes & activities

Clinical research of the radiation oncology department

  • Implementation of functional imaging (FDG PET/CT, DCE MRI, DW-MRI) and adaptive radiotherapy in head and neck
  • prostate and rectal cancer
  • SBRT for oligometastatic disease
  • SFRT for brain metastases
  • Ultrahypofractionation with simultaneaously integrated boost in prostate cancer
  • Protontherapy in esophageal cancer (PROTECT)

 

Ongoing projects/partnerships/collaborations

Translational research of the radiation oncology department

  • Identification of predictive and prognostic biomarkers in patients with head and neck, prostate, lung and rectal cancer.
  • Establishment of biobanks for scientific research: collection of tissue, blood, saliva and urine of patients with head and neck, prostate, lung and rectal cancer included in clinical studies